NHTC NATURAL HEALTH TRENDS CORP
Wholesale-Miscellaneous Nondurable Goods · Nasdaq · SEC CIK 912061 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-16.5%
TTM net income YoY-1,107.6%
TTM EPS YoY-1,300.0%
Revenue 3-yr CAGR-9.1%
Net income 3-yr CAGR—
Margins
Gross margin74.3%
Operating margin-5.9%
Net margin-4.2%
FCF margin-13.7%
EBITDA margin-5.7%
Returns
ROE-6.9%
ROA-4.1%
ROIC (approx.)-15.3%
Asset turnover0.98x
Leverage & solvency
Liabilities / assets45.0%
Debt / equity0.00x
Current ratio2.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.96x
Accruals ratio8.0%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $7.56M | $7.60M | $9.21M | $9.75M | $9.48M | $9.81M | $10.74M | $10.85M |
| Cost of revenue | $1.95M | $1.88M | $2.30M | $2.64M | $2.49M | $2.56M | $2.83M | $2.80M |
| Gross profit | $5.61M | $5.72M | $6.90M | $7.11M | $6.99M | $7.25M | $7.91M | $8.04M |
| SG&A expense | $3.17M | $3.25M | $3.52M | $3.81M | $3.61M | $3.58M | $3.76M | $3.92M |
| Operating income | -$277,000 | -$643,000 | -$474,000 | -$635,000 | -$495,000 | -$333,000 | -$345,000 | -$421,000 |
| Pretax income | -$165,000 | -$453,000 | -$179,000 | -$413,000 | -$289,000 | $15,000 | $120,000 | -$25,000 |
| Income tax | $67,000 | -$2,000 | -$25,000 | $175,000 | $142,000 | $0 | -$2,000 | -$201,000 |
| Net income | -$232,000 | -$451,000 | -$154,000 | -$588,000 | -$431,000 | $15,000 | $122,000 | $176,000 |
| EBITDA | -$243,000 | -$620,000 | -$463,000 | -$613,000 | -$467,000 | -$304,000 | -$315,000 | -$390,000 |
| EPS (basic) | -0.03 | -0.05 | -0.02 | — | -0.04 | 0.00 | 0.01 | — |
| EPS (diluted) | -0.03 | -0.05 | -0.02 | — | -0.04 | 0.00 | 0.01 | — |
| Dividends declared per share | — | 0.10 | 0.10 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Weighted avg. shares (diluted) | 8.58M | 8.58M | 10.14M | — | 11.50M | 11.50M | 11.49M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $5.82M | $9.50M | $9.22M | $6.81M | $14.34M | $10.53M | $21.69M | $13.53M |
| Short-term investments | $11.77M | $9.12M | $12.01M | $22.06M | $17.67M | $23.71M | $20.21M | $30.41M |
| Inventory | $2.05M | $2.05M | $1.97M | $2.05M | $2.15M | $2.77M | $2.81M | $3.27M |
| Current assets | $21.96M | $23.70M | $26.54M | $34.19M | $37.89M | $40.86M | $48.81M | $50.98M |
| PP&E, net | $542,000 | $570,000 | $258,000 | $153,000 | $170,000 | $154,000 | $176,000 | $190,000 |
| Total assets | $27.26M | $29.21M | $31.95M | $38.43M | $42.25M | $45.16M | $53.18M | $55.36M |
| Current liabilities | $10.33M | $11.94M | $13.24M | $13.69M | $14.76M | $14.95M | $20.74M | $20.80M |
| Total liabilities | $12.26M | $14.01M | $15.49M | $15.00M | $16.10M | $16.31M | $22.30M | $22.49M |
| Shareholders' equity | $15.00M | $15.20M | $16.46M | $23.43M | $26.15M | $28.86M | $30.88M | $32.87M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.09M | -$1.36M | -$797,000 | -$959,000 | $113,000 | -$5.63M | $484,000 | $88,000 |
| Capital expenditure | $7,000 | $325,000 | $115,000 | $5,000 | $43,000 | $4,000 | $16,000 | $20,000 |
| Free cash flow | -$1.10M | -$1.69M | -$912,000 | -$964,000 | $70,000 | -$5.64M | $468,000 | $68,000 |
| Investing cash flow | -$2.61M | $2.47M | $9.94M | -$4.40M | $5.90M | -$3.33M | $9.97M | -$6.99M |
| Financing cash flow | -$28,000 | -$858,000 | -$6.73M | -$2.30M | -$2.30M | -$2.30M | -$2.30M | -$2.30M |
| Depreciation & amortization | $34,000 | $23,000 | $11,000 | $22,000 | $28,000 | $29,000 | $30,000 | $31,000 |
| Stock-based compensation | $0 | $0 | $0 | $29,000 | $35,000 | $34,000 | $34,000 | $36,000 |
| Dividends paid | $0 | $858,000 | $858,000 | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M |
| Share buybacks | $28,000 | $0 | $5.87M | — | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.